Diagnosis and Application of Combine Detection on Pyridine Cross-linked Comprehensive Peptide of Type Ⅰ Collagen,Matrix Metalloproteinase Enzyme-3 Projects,CCP and RF in Patients with Early Rheumatoid Arthritis
Dong Yiyu,Zhang Xingen,Lu Jianliang
2013-01-01
Abstract:Objective To explore the end of the cross-linking of type I collagen pyridine final peptide pyridine(ICTP),matrix metalloenzymes-3 and(MMP-3),anti-cyclic citrullinated peptide(CCP) antibodies,rheumatoid factor(RF) detection for early rheumatoid arthritis(RA) patients and the predictive value of the disease process.Methods From January 2010 to June 2012,249 cases of rheumatism in outpatient department and hospitalized patients with RA(RA group,which 121 cases were early RA) and 41 cases of non-RA patients with other immune system diseases(non-RA control group) and 60 cases of healthy subjects(healthy control group),using quantitative ELISA to measure serum ICTP,MMP-3,anti-CCP antibodies.Besides,serum RF with turbidimetric immunoassay.Results(1) Anti-CCP,RF serum levels in RA on average showed significantly higher than non-RA and the control group(P<0.01).A comparison of ICTP,MMP-3,RF levels in the non-RA group higher than the normal group(P<0.01),presented statistically significant difference in early RA and non-RA group,ICTP indicated no statistical significance(P>0.05);MMP-3 has a higher content in the middle and late period,which manifested markedly higher than the other groups(P<0.01) obvious difference(P>0.05) compared to early RA patients with long-term RA group compared with the normal control group,were different(P<0.01).(2) Among anti-CCP,ICTP,MMP-3 and the RF showed no statistically significance(P>0.05),but might be used as an indicator in early diagnosis of RA.(3) ICTP,MMP-3,anti-CCP and anti RF four serum standards,combined detection of early RA diagnosis,the sensitivity 43.8% and specificity 99.0% individually,decreased in the sensitivity for diagnosis of early RA,but the specificity increased.Conclusion Combined detection of four serum indicators,can reduce the rate of misdiagnosis of RA.Dynamic joint determination of ICTP,anti-CCP antibodies,RF and MMP-3 could be more effective and timely monitoring of disease progression in RA also guiding clinical treatment and intervention.